Real-world variability in dabigatran levels in patients with atrial fibrillation-Reference-Cited by-同舟云学术

Real-world variability in dabigatran levels in patients with atrial fibrillation

Published:2015-01-28 Issue:3 Volume:13 Page:353-359
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Chan N. C.¹,Coppens M.²,Hirsh J.³,Ginsberg J. S.³⁴,Weitz J. I.³⁴,Vanassche T.¹,Douketis J. D.³⁴,Schulman S.³⁴,Eikelboom J. W.¹³⁴

Affiliation:

1. Population Health Research Institute; Hamilton ON Canada

2. Department of Vascular Medicine; Academic Medical Center; Amsterdam the Netherlands

3. Department of Medicine; McMaster University; Hamilton ON Canada

4. Thrombosis and Atherosclerosis Research Institute; Hamilton ON Canada

Funder

Hamilton Health Sciences New Investigator

Boehringer Ingelheim

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12823/fullpdf

Reference16 articles.

1. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

2. Health Canada Pradaxa product monograph DIN 02312441 http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp

3. U.S. Food and Drug Administration Pradaxa prescribing information http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022512s017lbl.pdf

4. European Medicines Agency Pradaxa summary of product characteristics http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf

5. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy);Reilly;J Am Coll Cardiol,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation;Frontiers in Pharmacology;2024-05-10

2. Extremely elevated international normalized ratio in a patient using dabigatran etexilate: a case report;Journal of Neurocritical Care;2023-12-19

3. The potential use of laboratory monitoring during individualizing the dosage of direct oral anticoagulants - a literature review;Vnitřní lékařství;2023-10-26

4. Navigating the twilight zone of DOAC plasma monitoring;Thrombosis Research;2023-05

5. Variability and Clinical Characteristics of Anti-factor Xa Activity Treated with Rivaroxaban in Chinese Patients Aged ≥ 80 years: A Single-center Study;2023-04-10